Dendritic cell vaccination for metastatic melanoma: a 14-year monoinstitutional experience-Reference-Cited by-同舟云学术

Dendritic cell vaccination for metastatic melanoma: a 14-year monoinstitutional experience

Published:2017-08 Issue:4 Volume:27 Page:351-357
ISSN:0960-8931
Container-title:Melanoma Research
language:en
Short-container-title:

Author:

de Rosa Francesco,Ridolfi Laura,Fiammenghi Laura,Petrini Massimiliano,Granato Anna M.,Ancarani Valentina,Pancisi Elena,Soldati Valentina,Cassan Serena,Bulgarelli Jenny,Framarini Massimo,Tauceri Francesca,Migliori Giuseppe,Brolli Claudia,Gentili Giorgia,Petracci Elisabetta,Nanni Oriana,Riccobon Angela,Ridolfi Ruggero,Guidoboni Massimo

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Dermatology,Oncology

Reference35 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int J Cancer,2015

2. Improved survival with ipilimumab in patients with metastatic melanoma;Hodi;N Engl J Med,2010

3. Pembrolizumab versus ipilimumab in advanced melanoma;Robert;N Engl J Med,2015

4. Nivolumab in previously untreated melanoma without BRAF mutation;Robert;N Engl J Med,2015

5. Improved survival with vemurafenib in melanoma with BRAF V600E mutation;Chapman;N Engl J Med,2011

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First step results from a phase II study of a dendritic cell vaccine in glioblastoma patients (CombiG-vax);Frontiers in Immunology;2024-08-13

2. Targeting anticancer immunity in melanoma tumour microenvironment: unleashing the potential of adjuvants, drugs, and phytochemicals;Journal of Drug Targeting;2024-08-07

3. Dendritic cell vaccines as cancer treatment: focus on 13 years of manufacturing and quality control experience in advanced therapy medicinal products;Cytotherapy;2024-07

4. Autologous dendritic cells loaded with antigens from self-renewing autologous tumor cells as patient-specific therapeutic cancer vaccines;Human Vaccines & Immunotherapeutics;2023-01-02

5. Stability Program in Dendritic Cell Vaccines: A “Real-World” Experience in the Immuno-Gene Therapy Factory of Romagna Cancer Center;Vaccines;2022-06-23